Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
利用HLA II类限制性T细胞受体靶向KRAS突变治疗实体瘤
期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2021.1936757
Dillard, Pierre; Casey, Nicholas; Pollmann, Sylvie; Vernhoff, Patrik; Gaudernack, Gustav; Kvalheim, Gunnar; Wälchli, Sébastien; Inderberg, Else Marit
